Research

GSK’s Arexvy vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia

October 3, 2024

KUALA LUMPUR, Oct 3 — GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Mala…

KUALA LUMPUR, Oct 3 — GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Mala…
Read More

About Author

Malay Mail

See author's posts

Research

Celebration as Nigerian Air Force pharmacist wins 3 prestigious awards, details emerge

November 18, 2024

Research

Stock Market Tanks as Trump Unveils Nightmare Cabinet Picks

November 15, 2024

New drug targets for Alzheimer's identified from cerebrospinal fluid

November 15, 2024 0

Cytomos raises $5m to scale up cell analysis technology production

November 21, 2024

Researchers zero in on genetic variant tied to miscarriages

Researchers zero in on genetic variant tied to miscarriages

November 21, 2024

Cities, states say they’ll need more help to replace millions of lead pipes

Cities, states say they’ll need more help to replace millions of lead pipes

November 21, 2024

Nationwide, couple-based reproductive carrier screening program demonstrates feasibility

Nationwide, couple-based reproductive carrier screening program demonstrates feasibility

November 21, 2024

Study assesses risk for 28-day hospitalization for adults with RSV

Study assesses risk for 28-day hospitalization for adults with RSV

November 21, 2024